Here is the article..."Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide AE37 vaccine in breast cancer patients to prevent recurrence"


https://pubmed.ncbi.nlm.nih.gov/27029708/





RJS wrote:

https://www.facebook.com/BrookeArmyMedicalCen...31/?type=3

Post from 4 days ago.